Systemic therapy for hereditary cancer

被引：0
|
作者：
Evgeny N Imyanitov
机构：
[1] N.N. Petrov Institute of Oncology,
[2] St.-Petersburg Pediatric Medical Academy,undefined
[3] I.I. Mechnikov North-Western Medical University,undefined
来源：
Hereditary Cancer in Clinical Practice | / 10卷 / Suppl 4期
关键词：
Thyroid Cancer; Everolimus; Tuberous Sclerosis; Sulindac; Liposomal Doxorubicin;
D O I：
10.1186/1897-4287-10-S4-A16
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Impact of genetic alterations on mTOR-targeted cancer therapy
    Sun, Shi-Yong
    CHINESE JOURNAL OF CANCER, 2013, 32 (05) : 270 - 274
  • [42] Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer
    Basho, Reva K.
    Yam, Clinton
    Gilcrease, Michael
    Murthy, Rashmi K.
    Helgason, Thorunn
    Karp, Daniel D.
    Meric-Bernstam, Funda
    Hess, Kenneth R.
    Valero, Vicente
    Albarracin, Constance
    Litton, Jennifer K.
    Chavez-MacGregor, Mariana
    Hong, David
    Kurzrock, Razelle
    Hortobagyi, Gabriel N.
    Janku, Filip
    Moulder, Stacy L.
    ONCOLOGIST, 2018, 23 (11) : 1300 - 1309
  • [43] The concomitant management of cancer therapy and cardiac therapy
    Salvatorelli, Emanuela
    Menna, Pierantonio
    Cantalupo, Emilia
    Chello, Massimo
    Covino, Elvio
    Wolf, Federica I.
    Minotti, Giorgio
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2015, 1848 (10): : 2727 - 2737
  • [44] Systemic therapy for chromophobe renal cell carcinoma: A systematic review
    Papanikolaou, Dimitrios
    Ioannidou, Pinelopi
    Koukourikis, Periklis
    Moysidis, Kyriakos
    Meditskou, Soultana
    Koutsoumparis, Dimitrios
    Hatzimouratidis, Konstantinos
    Hatzivassiliou, Eudoxia
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (04) : 137 - 149
  • [45] Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma
    de Velasco, Guillermo
    Bex, Axel
    Albiges, Laurence
    Powles, Thomas
    Rini, Brian I.
    Motzer, Robert J.
    Heng, Daniel Y. C.
    Escudier, Bernard
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 505 - 514
  • [46] Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy
    Lo, Mindy S.
    Tsokos, George C.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (02) : 222 - 228
  • [47] Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
    Cummings, Shelly
    Alfonso, Andrew
    Hughes, Elisha
    Kucera, Matt
    Mabey, Brent
    Singh, Nanda
    Eng, Charis
    JCO PRECISION ONCOLOGY, 2023, 7
  • [48] Advanced renal cell carcinoma - an overview of current systemic therapy
    Kaune, Moritz
    Bokemeyer, Carsten
    von Amsberg, Gunhild
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (04) : 180 - 190
  • [49] Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group
    MacFarland, Suzanne P.
    Becktell, Kerri
    Schneider, Kami Wolfe
    Kuiper, Roland P.
    Lesmana, Harry
    Meade, Julia
    Nichols, Kim E.
    Porter, Christopher C.
    Savage, Sharon A.
    Schultz, Kris Ann
    Scott, Hamish
    States, Lisa
    Tabori, Uri
    Tamura, Chieko
    Tomlinson, Gail
    Zelley, Kristin
    Durno, Carol
    Bauer, Andrew
    Plon, Sharon E.
    CLINICAL CANCER RESEARCH, 2024, 30 (20) : 4566 - 4571
  • [50] Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy
    Leung, Roland
    Lang, Brian
    Wong, Hilda
    Chiu, Joanne
    Yat, Wan K.
    Shek, Tony
    Cho, Woo Y.
    Yau, Lo C.
    Yau, Thomas
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (03) : 382 - 388
12345